Physician profile
Isadora Fox
NPI 1962748202
$1,177.03
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $515 · 2023: $229 · 2024: $103 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.92 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.18 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $187.86 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $183.14 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $117.77 | 2022-2023 | Trintellix |
| Alkermes, INC. | $86.96 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $68.65 | 2021 | |
| Corium, LLC | $46.95 | 2023-2025 | Azstarys |
| Axsome Therapeutics, INC. | $41.13 | 2023-2025 | Auvelity |
| Bausch Health US, LLC | $34.75 | 2022 | |
| Supernus Pharmaceuticals, INC. | $27.66 | 2023-2024 | Qelbree, Qelbree |
| Alfasigma USA, INC. | $26.51 | 2022 | |
| Tms Neurohealth Centers INC. | $20.09 | 2025 | Tms Neurohealth Centers INC. |
| Lundbeck LLC | $18.02 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.04 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.28 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $14.64 | 2023 | Secuado |
| Vanda Pharmaceuticals INC. | $14.32 | 2025 | Fanapt |
| Ironshore Pharmaceuticals INC. | $13.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isadora Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.